Medical Design Technology -
1 Dec 2016 21:12
News In the new study, the investigators developed a new antibody called 11B6 to target human kallikrein-related peptidase 2 (hK2), another antigen that indicates androgen receptor pathway activation. Contributed Author: Johns Hopkins Medicine Topics: Medical Diagnostics
Share this Article